MCT12 inhibitors are a class of chemical compounds that specifically target and inhibit the function of the Monocarboxylate Transporter 12 (MCT12), also known as SLC16A12. MCT12 is a member of the solute carrier family 16, which is involved in the transport of monocarboxylates across cell membranes. These transporters play a crucial role in the cellular uptake and efflux of metabolic intermediates, such as lactate, pyruvate, and other monocarboxylates, which are essential for various metabolic pathways. By inhibiting MCT12, researchers can explore the role of this transporter in cellular metabolism and its impact on physiological processes.
In scientific research, MCT12 inhibitors serve as valuable tools for investigating the regulatory mechanisms of monocarboxylate transport and the metabolic pathways they influence. These inhibitors allow scientists to study how the inhibition of MCT12 affects cellular metabolism, energy production, and the overall metabolic flux within cells. Additionally, MCT12 inhibitors can help elucidate the transporter's role in specific tissues and organs, particularly in relation to their metabolic demands and functional activities. For instance, understanding how MCT12 contributes to metabolic processes in tissues such as the kidney, where it is highly expressed, can provide insights into the organ-specific roles of monocarboxylate transporters. Overall, the use of MCT12 inhibitors in research enhances our comprehension of metabolic regulation and the intricate network of transporters that maintain cellular homeostasis.
产品名称 | CAS # | 产品编号 | 数量 | 价格 | 应用 | 排名 |
---|---|---|---|---|---|---|
Lonidamine | 50264-69-2 | sc-203115 sc-203115A | 5 mg 25 mg | ¥1162.00 ¥4028.00 | 7 | |
洛尼达明直接抑制SLC16A,阻断乳酸运输并破坏细胞代谢。 | ||||||
ACY-1215 | 1316214-52-4 | sc-507455 | 25 mg | ¥1241.00 | ||
AZD3965直接与SLC16A结合,成为阻断乳酸运输的高效选择性抑制剂。AZD3965是SLC16A和MCT2的选择性抑制剂,阻碍乳酸和丙酮酸穿过质膜。 | ||||||
Bumetanide (Ro 10-6338) | 28395-03-1 | sc-200727 sc-200727A | 1 g 5 g | ¥1207.00 ¥2527.00 | 9 | |
布美他尼虽然主要是一种利尿剂,但已被证明可通过影响相关细胞过程间接抑制SLC16A。 | ||||||
Cabozantinib L-Malate Salt | 1140909-48-3 | sc-504572 | 10 mg | ¥3046.00 | ||
AR-C155858是一种强效且选择性的MCT2抑制剂。它通过阻断MCT2转运蛋白来抑制乳酸转运,从而阻止细胞摄取乳酸。 | ||||||
Hydrazine sulfate | 10034-93-2 | sc-211599 sc-211599A | 5 g 100 g | ¥530.00 ¥756.00 | ||
抑制多种氨基转移酶,可通过竞争性抑制干扰SLC16A的功能。 | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | ¥1038.00 ¥2358.00 | 33 | |
抑制二氢叶酸还原酶,可能导致代谢物堆积,间接抑制SLC16A。 | ||||||
Methylene blue | 61-73-4 | sc-215381B sc-215381 sc-215381A | 25 g 100 g 500 g | ¥474.00 ¥1151.00 ¥3633.00 | 3 | |
一种氧化还原循环剂,可调节细胞氧化还原状态,从而影响SLC16A活性。 | ||||||
Phenethyl-hydrazine | 51-71-8 | sc-331686 | 500 mg | ¥4377.00 | ||
一种非选择性单胺氧化酶抑制剂,可改变与SLC16A相关的代谢途径。 | ||||||
Hydroxylamine solution | 7803-49-8 | sc-250136 | 100 ml | ¥801.00 | ||
一般氨基转移酶抑制剂,可通过活性位点的共价修饰抑制SLC16A。 | ||||||
Pyridoxal-5-phosphate | 54-47-7 | sc-205825 | 5 g | ¥1151.00 | ||
维生素B6的活性形式和氨基转移酶的辅助因子,其类似物可作为SLC16A的抑制剂。 |